Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

By sjmartinez • April 15, 2024

Weld ED, McGowan I, Anton P, Fuchs EJ, Ho K, Carballo-Dieguez A, Rohan LC, Giguere R, Brand R, Edick S, Bakshi RP, Parsons T, Manohar M, Seigel A, Engstrom J, Elliott J, Jacobson C, Bagia C, Wang L, Al-Khouja A, Hartman DJ, Bumpus NN, Spiegel HML, Marzinke MA, Hendrix CW. Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01). J Infect Dis. 2024 Apr 12;229(4):1131-1140. doi: 10.1093/infdis/jiad535. PMID: 38019657; PMCID: PMC11011183.

Tags: Digestive Diseases, HIV, Microbicide, Pharmacodynamics, Pharmacokinetics, phase 1, preexposure prophylaxis, Publications

Dietary Therapies for Gastrointestinal Disorders

Limketkai BN, Shin A, Manitius N, Rau S, Smith J, Shah ND. Dietary Therapies for Gastrointestinal Disorders. Nutrients. 2026 Jun 1;18(11):1787. doi: 10.3390/nu18111787. PMID: 42280430.

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1

Lim A, Peluso EM, Downs IA, Horwich BH, Velez-Velez MA, Lechner MG. Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome[...]

Comparative evaluation of bipolar versus monopolar energy platforms in G-POEM for gastroparesis: technical performance, learning curves, and clinical outcomes

Sarici IS, Khataniar H, Kolb JM, Eriksson SE, Newhams K, Albus K, Zheng P, Ayazi S. Comparative evaluation of bipolar versus monopolar energy platforms in[...]